LONG [eLong] SC 13E3: (Original Filing)

[eLong, Inc. , 2016 Shareholders of eLong, Inc. Re: Notice of Extraordinary General Meeting of Shareholders Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of shareholders of eLong, Inc. (the “Company”) to be held on , 2016 at a.m. (Hong Kong Time). The meeting will be held at Xingke Plaza, Tower B, Third Floor, 10 Middle] [EQUITY COMMITMENT LETTER Tencent Asset Management Limited February 4, 2016 China E-dragon Holdings Limited Ladies and Gentlemen: Merger Agreement Merger Sub Company Merger Other Sponsor Other Sponsor Equity Commitment Letter Sponsor Commitment Contribution Commitment 1. 1 Conditions 2. Limited Guarantee Limited Guarantee 3. Enforceability provided Section 6 Company Third Party Beneficiary Rights 4. No Modification; Entire Agreement 5. 2 Governing] [EQUITY COMMITMENT LETTER Ocean Imagination L.P. February 4, 2016 China E-dragon Holdings Limited Ladies and Gentlemen: Merger Agreement Merger Sub Company Merger Other Sponsor Other Sponsor Equity Commitment Letter Sponsor Commitment Contribution Commitment 1. Conditions 2. 1 to consummate the Transactions (other than those conditions that by their nature are to be satisfied at the Closing, but subject to the] [EQUITY COMMITMENT LETTER SEAGULL LIMITED February 4, 2016 China E-dragon Holdings Limited Ladies and Gentlemen: Merger Agreement Merger Sub Company Merger Other Sponsor Other Sponsor Equity Commitment Letter Sponsor Commitment Contribution Commitment 1. Conditions 2. 1 Closing, but subject to the prior or substantially concurrent satisfaction or waiver of such conditions), (c) the substantially contemporaneous consummation of the Closing, and] [EQUITY COMMITMENT LETTER JIANG HAO ( February 4, 2016 China E-dragon Holdings Limited Ladies and Gentlemen: Merger Agreement Merger Sub Company Merger Other Sponsor Other Sponsor Equity Commitment Letter Sponsor Commitment Contribution Commitment 1. 1 Conditions 2. Limited Guarantee 3. Enforceability provided Section 6 Company Third Party Beneficiary Rights 4. No Modification; Entire Agreement 5. 2 Governing Law; Jurisdiction 6.] [EQUITY COMMITMENT LETTER ZHOU RONG( February 4, 2016 China E-dragon Holdings Limited Ladies and Gentlemen: Merger Agreement Merger Sub Company Merger Other Sponsor Other Sponsor Equity Commitment Letter Sponsor Commitment Contribution Commitment 1. Conditions 2. 1 substantially contemporaneous consummation of the Closing, and (d) simultaneous funding of the contributions by the Other Sponsors contemplated by the Other Sponsor Equity Commitment] [eLong, Inc. Fairness Analysis Presented to the Special Committee of Independent Directors February 4, 2016 The information contained herein is of a confidential nature and is intended for the use of the persons or firm to whom it is furnished by us. Reproduction, publication, or dissemination of any portion hereof may not be made without prior approval of Duff &] [This statement is filed in connection with (check the appropriate box):]

By | 2016-03-28T07:59:54+00:00 February 26th, 2016|Categories: Chinese Stocks, LONG, SEC Original|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 8-K: (Original Filing)

[CHINA BIOLOGIC PRODUCTS, INC. AMENDED AND RESTATED DIRECTOR AGREEMENT Agreement Company Mr. David Li Director THIS AGREEMENT (this “ BACKGROUND Original Agreement The Director and the Company entered into a director agreement (the “ The Director and the Company desire to enter into this Agreement to amend and restate the Original Agreement in its entirety. AGREEMENT In consideration for the] [FOR RELEASE February 25, 2016 China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2015 4Q15 Total Sales Up 22.6% with Non-GAAP Net Income Up 44.5% YoY in RMB terms, or Up 17.8% YoY to $68.3 Million and 38.8% YoY to $20.4 Million in USD terms, respectively FY15 Total Sales Up 23.4% with Non-GAAP Net Income Up] []

ASX [ADVANCED SEMICONDUCTOR ENGINEERING] SC TO-T/A: (Original Filing)

[] [Investor communication  SPIL management continues to act at odds with corporate governance best practices and with total disregard for shareholder value • SPIL has declined multiple friendly attempts by ASE, the single largest shareholder in the company, to meet and discuss cooperation opportunities that would benefit shareholders of both companies • SPIL commenced baseless litigation against ASE using company]

By | 2016-03-20T08:49:00+00:00 February 25th, 2016|Categories: ASX, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

TEDU [Tarena International] SC 13G: (Original Filing)

[reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 subject to the liabilities of]

By | 2016-03-16T09:29:39+00:00 February 25th, 2016|Categories: Chinese Stocks, SEC Original, TEDU|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] IRANNOTICE: (Original Filing)

[China Biologic Products, Inc. 8th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China February 25, 2016 VIA EDGAR 100 F Street, N.E. Re: Notice of Disclosure Filed in Exchange Act Annual Report under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the]

VIPS [Vipshop] 6-K: (Original Filing)

[001-35454 Vipshop Holdings Limited No. 20 Huahai Street Liwan District, Guangzhou 510370 The People’s Republic of China Form 20-F x o o o Vipshop Reports Unaudited Fourth Quarter and Full Year 2015 Financial Results 4Q15 Total Net Revenue up 65% YoY to RMB13.90 Billion (US$2.15 Billion) 4Q15 Gross Profit up 60% YoY to RMB3.35 Billion (US$517 Million) 4Q15 Income from]

By | 2016-04-01T10:52:42+00:00 February 25th, 2016|Categories: Chinese Stocks, SEC Original, VIPS|Tags: , , , , , |0 Comments

SPIL [SILICONWARE PRECISION INDUSTRIES CO] SC TO-T/A: (Original Filing)

[] [Investor communication  SPIL management continues to act at odds with corporate governance best practices and with total disregard for shareholder value • SPIL has declined multiple friendly attempts by ASE, the single largest shareholder in the company, to meet and discuss cooperation opportunities that would benefit shareholders of both companies • SPIL commenced baseless litigation against ASE using company]

By | 2016-03-22T05:15:17+00:00 February 25th, 2016|Categories: Chinese Stocks, SEC Original, SPIL|Tags: , , , , , |0 Comments

YZC [YANZHOU COAL MINING CO] 6-K: (Original Filing)

[Yanzhou Coal Mining Company Limited Date By Zhang Baocai Director and Company Secretary YANZHOU COAL MINING COMPANY LIMITED (A joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 1171) ANNOUNCEMENT ON RESULTS OF THE ISSUANCE OF THE 2016 FIRST TRANCHE OF SUPER-SHORT-TERM BONDS Company Reference is made to the announcement of Yanzhou Coal]

By | 2016-03-23T00:02:11+00:00 February 25th, 2016|Categories: Chinese Stocks, SEC Original, YZC|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 10-K: (Original Filing)

[Annual Report on Form 10-K Year Ended December 31, 2015 TABLE OF CONTENTS PART I Item 1. Business 3 Item 1A. Risk Factors 24 Item 1B. Unresolved Staff Comments 45 Item 2. Properties 45 Item 3. Legal Proceedings 46 Item 4. Mine Safety Disclosures 48 PART II Item 5. 49 Item 6. Selected Financial Data 50 Item 7. Management’s Discussion] [CHINA BIOLOGIC PRODUCTS, INC. The subsidiaries of China Biologic Products, Inc. are as follows: Jurisdiction of Name Incorporation or Organization Ownership Interest Taibang Biological Ltd. BVI 100.0% Taibang Holdings (Hong Kong) Limited HK 100.0% Taibang Biotech (Shandong) Co., Ltd. Shandong PRC 100.0% Taibang (Beijing) Pharmaceutical Research Institute Co., Ltd. Beijing PRC 100.0% Shandong Taibang Biological Products Co., Ltd. Shandong PRC] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statement (No. 333-204761) on Form S-3 and the registration statement (No. 333-151263) on Form S-8 of China Biologic Products, Inc. of our reports dated February 25, 2016, with respect to the consolidated balance sheets of China Biologic Products, Inc.] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this annual report on Form 10-K of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this annual report on Form 10-K of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th David (Xiaoying) Gao Chief Executive Officer] [2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th Ming Yang Chief Financial Officer (Principal Financial and Accounting Officer)]

Skip to toolbar